Clinical case study challenges established paradigms on permanent cognitive and motor decline in age-related degenerative diseases.
Capsules containing donor stool microbes improved sleep efficiency and reduced nighttime wakefulness in adults with chronic insomnia.
Personalized genetic therapy helped researchers treat two children with a rare form of epilepsy, enabling one to walk independently for the first time.
Prions can turn the body’s own proteins into a threat, and studying this group of diseases could help us better understand dementia.
The FDA announced today that it selected Dexcom (Nasdaq:DXCM) as the first manufacturer for a new digital health pilot.
Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava surgical robot system.